KOO-KOO2's Recent Posts
Title Rating Company Posted on ▼
Re: One more Exempt Distribution - 2021-04-26 3 Resverlogix Corp. Apr 28, 2021 10:22AM
Re: One more Exempt Distribution - 2021-04-26 3 Resverlogix Corp. Apr 27, 2021 06:57PM
Re: Resverlogix’s Apabetalone Demonstrates a Medical First in Patients with Chronic Kidney Disease 1 Resverlogix Corp. Apr 27, 2021 03:32PM
Re: How many other "Alex Kopacz's" are out there...as we wait our turn on the tarmac? 5 Resverlogix Corp. Apr 27, 2021 11:55AM
Re: Study readouts this week or next? 1 BIOASIS TECHNOLOGIES INC Apr 27, 2021 09:37AM
Re: Study readouts this week or next? 1 BIOASIS TECHNOLOGIES INC Apr 27, 2021 08:54AM
Re: Where is the trial? 2 Resverlogix Corp. Apr 24, 2021 06:27PM
Re: Where is the trial? 2 Resverlogix Corp. Apr 24, 2021 06:52AM
Short Interest 3 Resverlogix Corp. Apr 23, 2021 09:31AM
Re: Still not finding on ClinicalTrials gov 1 Resverlogix Corp. Apr 23, 2021 05:32AM
Re: Still not finding on ClinicalTrials gov 1 Resverlogix Corp. Apr 22, 2021 08:53PM
Re: Still not finding on ClinicalTrials gov 1 Resverlogix Corp. Apr 22, 2021 07:50PM
Re: COVID 19 - Standard of Care 5 Resverlogix Corp. Apr 22, 2021 06:58PM
Re: Still not finding on ClinicalTrials gov 2 Resverlogix Corp. Apr 22, 2021 01:24PM
Re: ZEN-3694 and Enzalutamide 2b Trial 3 Zenith Epigenetics Apr 22, 2021 11:11AM
Re: Still not finding on ClinicalTrials gov 3 Resverlogix Corp. Apr 22, 2021 05:15AM
COVID 19 - Standard of Care 1 Resverlogix Corp. Apr 21, 2021 02:07PM
Merck (MRK) Stops MK-7110 Development, Focuses on Molnupiravir 4 Resverlogix Corp. Apr 19, 2021 09:08AM
Re: Posted on other board by jkj from Google alert / Old or new news? 1 Resverlogix Corp. Apr 19, 2021 07:53AM
Re: Another Exempt Distribution - 2021-04-15 2 Resverlogix Corp. Apr 18, 2021 08:26AM